Crown, J P <br/><br/>
Mitoxantrone, etoposide, mitoguazone and vinblastine chemotherapy (MV2) in relapsed and refractory lymphomas.  [electronic resource] 

 -  Investigational new drugs  May 1991 
 - 185-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0167-6997 
<br/><br/><label>Standard No.: </label>10.1007/BF00175086  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Drug Evaluation<br/>Etoposide--administration & dosage<br/>Hodgkin Disease--drug therapy<br/>Humans<br/>Lymphoma--drug therapy<br/>Middle Aged<br/>Mitoguazone--administration & dosage<br/>Mitoxantrone--administration & dosage<br/>Prognosis<br/>Prospective Studies<br/>Recurrence<br/>Remission Induction--methods<br/>Vinblastine--administration & dosage